1kye

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
(New page: 200px<br /> <applet load="1kye" size="450" color="white" frame="true" align="right" spinBox="true" caption="1kye, resolution 2.22&Aring;" /> '''Factor Xa in comple...)
Line 1: Line 1:
-
[[Image:1kye.gif|left|200px]]<br />
+
[[Image:1kye.gif|left|200px]]<br /><applet load="1kye" size="350" color="white" frame="true" align="right" spinBox="true"
-
<applet load="1kye" size="450" color="white" frame="true" align="right" spinBox="true"
+
caption="1kye, resolution 2.22&Aring;" />
caption="1kye, resolution 2.22&Aring;" />
'''Factor Xa in complex with (R)-2-(3-adamantan-1-yl-ureido)-3-(3-carbamimidoyl-phenyl)-N-phenethyl-propionamide'''<br />
'''Factor Xa in complex with (R)-2-(3-adamantan-1-yl-ureido)-3-(3-carbamimidoyl-phenyl)-N-phenethyl-propionamide'''<br />
==Overview==
==Overview==
-
A putative non-substrate like binding mode of (R)-3-amidinophenylalanine, derivatives to factor Xa, as derived from modeling experiments based on, X-ray analysis of their complexes with trypsin, was used to design a new, generation of inhibitors. However, the resulting inhibitory potencies were, not at all consistent with the working assumption, although with an, adamantyl-ureido derivative of (R)-3-amidinophenylalanine phenetyl amide a, highly selective nanomolar inhibition of factor Xa was achieved. The X-ray, analysis of the complex of this ligand with factor Xa revealed an, unexpected new binding mode, of which the most important feature is the, interaction of the C-terminal aryl moiety with a hydrophobic subregion of, the S1 subsite, while the adamantyl group occupies the hydrophobic S3/S4, subsites of the enzyme.
+
A putative non-substrate like binding mode of (R)-3-amidinophenylalanine derivatives to factor Xa, as derived from modeling experiments based on X-ray analysis of their complexes with trypsin, was used to design a new generation of inhibitors. However, the resulting inhibitory potencies were not at all consistent with the working assumption, although with an adamantyl-ureido derivative of (R)-3-amidinophenylalanine phenetyl amide a highly selective nanomolar inhibition of factor Xa was achieved. The X-ray analysis of the complex of this ligand with factor Xa revealed an unexpected new binding mode, of which the most important feature is the interaction of the C-terminal aryl moiety with a hydrophobic subregion of the S1 subsite, while the adamantyl group occupies the hydrophobic S3/S4 subsites of the enzyme.
==Disease==
==Disease==
Line 11: Line 10:
==About this Structure==
==About this Structure==
-
1KYE is a [http://en.wikipedia.org/wiki/Protein_complex Protein complex] structure of sequences from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens] with CA and RUP as [http://en.wikipedia.org/wiki/ligands ligands]. Active as [http://en.wikipedia.org/wiki/Coagulation_factor_Xa Coagulation factor Xa], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=3.4.21.6 3.4.21.6] Full crystallographic information is available from [http://ispc.weizmann.ac.il/oca-bin/ocashort?id=1KYE OCA].
+
1KYE is a [http://en.wikipedia.org/wiki/Protein_complex Protein complex] structure of sequences from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens] with <scene name='pdbligand=CA:'>CA</scene> and <scene name='pdbligand=RUP:'>RUP</scene> as [http://en.wikipedia.org/wiki/ligands ligands]. Active as [http://en.wikipedia.org/wiki/Coagulation_factor_Xa Coagulation factor Xa], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=3.4.21.6 3.4.21.6] Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1KYE OCA].
==Reference==
==Reference==
Line 20: Line 19:
[[Category: Bode, W.]]
[[Category: Bode, W.]]
[[Category: Moroder, L.]]
[[Category: Moroder, L.]]
-
[[Category: Mueller, M.M.]]
+
[[Category: Mueller, M M.]]
[[Category: Sperl, S.]]
[[Category: Sperl, S.]]
[[Category: Sturzebecher, J.]]
[[Category: Sturzebecher, J.]]
Line 28: Line 27:
[[Category: factor xa]]
[[Category: factor xa]]
-
''Page seeded by [http://ispc.weizmann.ac.il/oca OCA ] on Mon Nov 12 17:55:56 2007''
+
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Feb 21 13:39:18 2008''

Revision as of 11:39, 21 February 2008


1kye, resolution 2.22Å

Drag the structure with the mouse to rotate

Factor Xa in complex with (R)-2-(3-adamantan-1-yl-ureido)-3-(3-carbamimidoyl-phenyl)-N-phenethyl-propionamide

Contents

Overview

A putative non-substrate like binding mode of (R)-3-amidinophenylalanine derivatives to factor Xa, as derived from modeling experiments based on X-ray analysis of their complexes with trypsin, was used to design a new generation of inhibitors. However, the resulting inhibitory potencies were not at all consistent with the working assumption, although with an adamantyl-ureido derivative of (R)-3-amidinophenylalanine phenetyl amide a highly selective nanomolar inhibition of factor Xa was achieved. The X-ray analysis of the complex of this ligand with factor Xa revealed an unexpected new binding mode, of which the most important feature is the interaction of the C-terminal aryl moiety with a hydrophobic subregion of the S1 subsite, while the adamantyl group occupies the hydrophobic S3/S4 subsites of the enzyme.

Disease

Known disease associated with this structure: Factor X deficiency OMIM:[227600]

About this Structure

1KYE is a Protein complex structure of sequences from Homo sapiens with and as ligands. Active as Coagulation factor Xa, with EC number 3.4.21.6 Full crystallographic information is available from OCA.

Reference

(R)-3-Amidinophenylalanine-derived inhibitors of factor Xa with a novel active-site binding mode., Mueller MM, Sperl S, Sturzebecher J, Bode W, Moroder L, Biol Chem. 2002 Jul-Aug;383(7-8):1185-91. PMID:12437104

Page seeded by OCA on Thu Feb 21 13:39:18 2008

Proteopedia Page Contributors and Editors (what is this?)

OCA

Personal tools